[1]
Centonze, D. et al. 2016. [Pegylation and interferons in multiple sclerosis]. Farmeconomia. Health economics and therapeutic pathways. 17, 2S (Jul. 2016), 5–11. DOI:https://doi.org/10.7175/fe.v17i2S.1229.